top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Agents : Design, Synthesis and Evaluation
Anticancer Agents : Design, Synthesis and Evaluation
Autore Chen Qiao-Hong
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (606 p.)
Soggetto topico Medicine
Soggetto non controllato benzofurans
chemical synthesis
cytotoxic properties
HeLa
MOLT-4
K562
anticancer
anti-neuroinflammation
coumarin
dihydroartemisinin
flavonoids
allene
E-stereoselective
regioselective
anti-cancer activity
cyanopyridone
substituted pyridine
pyridotriazine
pyrazolopyridine
thioxotriazopyridine
anticancer activity
HepG2
antitumor activity
computational docking
MDM2-p53 interaction
xanthones
yeast-based assays
estrone derivatives
hydrazine
N-substituted pyrazoline
anti-ovarian cancer
topoisomerase II inhibitor
kinase inhibitor
antiproliferative agent
urea
synthesis
antiproliferative activity
apoptosis
indoleamine 2,3-dioxygenase
inhibitor
anti-tumor
immune modulation
tryptophan metabolism
taxoids
βIII-tubulin
P-glycoprotein
drug resistance
thiopene
thienopyrimidinone
thiazolidinone
breast cancer
benzofuran–pyrazole
nanoparticles
cytotoxic activity
PARP-1 inhibition
3,6-dibromocarbazole
5-bromoindole
carbazole
actin
migration
Thienopyrimidine
Pyrazole
PI3Kα inhibitor
quinazolin-4(3H)-one
quinazolin-4(3H)-thione
Schiff base
antioxidant activity
DFT study
ortho-quinones
beta-lapachone
tanshione IIA
PI3Ks
PI3Kδ inhibitors
2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide
anticancer agents
protein–protein interactions
virtual screening
mimetics
drug discovery
bivalency
polyvalency
antitumor
cell cycle
ovarian cancer
P-MAPA
IL-12
TLR signaling
inflammation
chemoresistance
4-(pyridin-4-yloxy)benzamide
1,2,3-triazole
c-Met
natural product
anticancer agent
zampanolide
Talazoparib
PARP inhibitor
prodrug
o-nitro-benzyl
photoactivatable protecting groups
salinomycin
overcoming drug resistance
tumor specificity
synergy
5-fluorouracil
gemcitabine
amides/esters
colchicine analogs
thiocolchicine
colchiceine
antimitotic agents
hydrates
dihydropyranoindole
HDAC inhibitors
neuroblastoma
aromatase
MCF-7
NIH3T3
benzimidazole
triazolothiadiazine
docking
ADME
organosilicon compounds
SILA-409 (Alis-409)
SILA-421 (Alis-421)
multidrug resistance (MDR) reversal
ABCB1 (P-glycoprotein)
colon cancer
colchicine amide
colchicine sulfonamide
tubulin inhibitors
docking studies
crystal structure
PROTACs
protein degradation
IGF-1R
Src
protein kinase
phenylpyrazolopyrimidine
enzyme inhibition
molecular simulation
androgen receptor
prostate cancer
enzalutamide
apalutamide
darolutamide
triple-negative breast cancer
cytotoxicity
chrysin analogues
flavonoid
anticancer compounds
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Anticancer Agents
Record Nr. UNINA-9910557129103321
Chen Qiao-Hong  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Biomarker Research and Personalized Medicine
Cancer Biomarker Research and Personalized Medicine
Autore Meehan James
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (428 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato clear cell renal cell carcinoma
radiomics
WHO/ISUP nuclear grade
multiphasic multidetector computed tomography
triple-negative breast cancer
taxane
chemotherapy
GBP5
Akt/mTOR
autophagy
IL13Rα2
renal cell carcinoma
JAK2
FOXO3
telmisartan
ovarian cancer
bioinformatics
CREB1
drug perturbation
lincRNA-p21
rectal cancer
chemoradiotherapy
colorectal cancer
long non-coding RNA
p53
predictive biomarker
intestinal anastomosis
anastomotic leak
biomarkers
precision medicine
personalized medicine
biomarker
AmpliSeq
DNA methylation
epigenetics
head and neck cancer
saliva
liquid biopsy
meta-analysis
gastric cancer
middle-up-down
haptoglobin
glycopeptide
mass spectrometry
circulating tumor cells
prostate cancer
cancer vaccine
immune response
breast cancer
predictive tools
prognostic tools
translational research
IL6ST
gp130
cytokine signalling
tissue-based biomarkers
liquid-based biomarkers
radiotherapy
radiosensitivity biomarkers
secretome
radioresistance
bladder tumor
lymphocyte-to-monocyte ratio
peripheral blood parameters
tumor recurrence
transurethral resection
lipidomics
1H-NMR
LC-MS/MS
lipoprotein subfractions
lipoprotein lipase
cancer biomarkers
hepatocellular carcinoma
p16 expression
head and neck squamous cell carcinoma
HPV genotyping
exosomes
chemoresistance
comparative oncology
One Health
microRNA
lymph node metastasis
hormone-dependent carcinogenesis
localized prostate cancer
prognostic factors
HNSCC
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910674370003321
Meehan James  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunotherapy, Tumor Microenvironment and Survival Signaling
Immunotherapy, Tumor Microenvironment and Survival Signaling
Autore Golubovskaya Vita
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (376 p.)
Soggetto topico Medicine
Clinical & internal medicine
Soggetto non controllato Autophagy
colorectal cancer
immunotherapy
tumor stroma
tumor microenvironment
immune checkpoint inhibitors
chemotherapy
tyrosine kinase inhibitors
angiogenesis
check point inhibitors
programmed cell death protein 1
programmed cell death 1 ligand 1
cardiotoxicity
lung metastasis
CAR-T
hypoxia
tumor
microenvironment
CD19
BCMA
cancer
melanoma
immune escape
antigen loss
chimeric antigen receptor
electroporation
lentivirus
lentiviral transduction
macrophages
leukemia cells
lytic peptides
targeted therapy
dendritic cells
pathogenesis
risk factors
breast cancer
resistance
checkpoint
targeted treatment
personalized medicine
pediatric solid tumors
chimeric antigen receptors
cancer vaccines
oncolytic viral therapy
immunomodulation
DCLK1
tumor stem cells
clonogenicity
mitochondria
mitochondrial transfer
tunneling nanotubes
triple-negative breast cancer
immune checkpoint inhibitor
combination therapy
cancer nanomedicine
tumor antigens
cancer metabolism
cancer immunotherapy
nanoparticles
immunotherapeutic agent
immunomodulators
tuft cells
cancer stem cells
immunotherapies
myeloid-derived suppressor cells
regulatory T cells
crosstalk
tumor immune evasion
cell-cell contact
β2 integrins
CD18
CD11
CAR-T cells
CD37
cell therapy
tumor antigen
lymphoma
CAR macrophage
CAR T cell
solid tumors
immunometabolism
miRNA
immunogenic cell death
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580205403321
Golubovskaya Vita  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Pathways in Cancers
Molecular Pathways in Cancers
Autore Cristóbal Ion
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (284 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato actin cytoskeletal reorganization
breast cancer
CD99 agonist
EGFR dimerization
endocytosis
FAK dephosphorylation
PTPN12
Rac1
RhoA
tripeptide
OMD
PRELP
tumor suppression gene
bladder cancer initiation
tight junction
partial EMT
tousled-like kinase (TLK)
NIMA-related kinase 1 (NEK1)
yes-associated protein 1 (YAP1)
thioridazine (THD)
MS-determined phosphopeptides
human immunodeficiency virus type 1
epithelial cells
carcinogenicity
oxidative stress
reactive oxygen species
gp120
Tat
Nef
matrix protein p17
reverse transcriptase
mitochondria
metastasis
OXPHOS
cancer
Warburg effect
cancer therapeutics
myeloproliferative neoplasms
signaling pathways
JAK2
CALR
MPL
TPOR
DUSP1
MAPK
Snail
prostate cancer
migration and invasion
patient survival
biomarkers
pBRD4
SET
PP2A
prognosis
triple negative breast cancer
resistance
anti-receptor therapy
trastuzumab
PI3K
mTOR
TAK-228
epigenetic
methylation
acetylation
non-coding RNA
small-cell lung cancer
triple-negative breast cancer
pancreatic ductal adenocarcinoma
glioblastoma
metastatic melanoma
advanced ovarian cancer
hepatocellular carcinoma
immune evasion
immunotherapy
immune checkpoint inhibitors
oncogenic signaling pathway
molecular targeted agents
genome
epigenome
tumor immune microenvironment
ovarian cancer
adaptive immunity
innate immunity
complement system
cancer immunology
tumor microenvironment
splicing pathway
luminal breast cancer
BET inhibitors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566473703321
Cristóbal Ion  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Natural Phenolic Compounds for Health, Food and Cosmetic Applications
Natural Phenolic Compounds for Health, Food and Cosmetic Applications
Autore Panzella Lucia
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (230 p.)
Soggetto topico Medicine
Soggetto non controllato agri-food waste
exhausted wood
antioxidant
DPPH assay
FRAP assay
tannins
heavy metals
methylene blue
nitric oxides
acid hydrolysis
tyrosol
homovanillyl alcohol
hydroxytyrosol
dimethyl carbonate
lipophilic alkyl esters
hydroxytyrosol-enriched extracts
Olea europaea
green chemistry
circular economy
feijoa extracts
mercury
red blood cells
oxidative stress
glutathione
thiol groups
functional food
resveratrol
nanostructured lipid carriers (NLC)
factorial design
high shear homogenization
ultrasound method
analysis of variance (ANOVA)
spray drying
blueberry juice-maltodextrins
conservation of antioxidants
encapsulation
electrospinning
polyphenol
açaí (Euterpe oleracea Mart.)
zein
antioxidants
orange essential oil
xoconostle
maturation
antioxidant activity
ginsenosides
Panax quinquefolius
puffing
mentha
heat stress
antioxidant enzyme activity
salicylic acid
melatonin
essential oil
solubility
nanoparticle
correlation
supercritical fluid
bioavailability
cannabidiol
cannabidiol synthetic derivatives
endocannabinoids
lipid peroxidation
inflammation
membrane receptors
propolis
cytotoxic
antibacterial
México
HS-SPME/GC-MS-TOF
NMR
volatile compounds
flavonoids
phenolic acids
isoliquiritigenin (ISL)
triple-negative breast cancer
apoptosis
autophagy
5,6-dihydroxyindole-2-carboxylic acid
gelatin
cross-linked hydrogel
controlled release
melanins
photoprotection
UVA
HaCaT cells
reactive oxygen species
Nrf-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557628703321
Panzella Lucia  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action
Novel Anti-cancer Agents and Cellular Targets and Their Mechanism(s) of Action
Autore Allison Simon J
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (206 p.)
Soggetto topico Technology: general issues
History of engineering & technology
Soggetto non controllato microtubule acetylation
triple-negative breast cancer
anti-cancer agent
apoptosis
K562
8-hydroxydaidzein
autophagy
BCR-ABL
MAPK
NF-κB
c-myc
RNA interference
siRNA
oncogene
gene silencing
expression
nanosystems
Cytochrome P450
CYP1A1
CYP1B1
CYP2W1
breast cancer
prodrug
bioprecursor
duocarmycin
phortress
AQ4N
5-FU resistance
colorectal cancer
drug repurposing
Genomics of Drug Sensitivity in Cancer
Connectivity Map
anticancer drug
B-lactam steroid alkylators
synthetic lethality
poly (ADP-ribose) polymerase inhibitors
ovarian cancer
hybrid steroidal alkylating agents
migration
invasion
glioblastoma
CCN1
mesenchymal-amoeboid transition
biomarker
HepG2
Huh7
isatin sulfonamides
angiogenesis
cancer hallmarks
molecular docking
EGFR tyrosine kinase inhibitor
photon upconversion
triplet-triplet annihilation
in vivo imaging
PLGA
nanoparticles
affibody molecule
human epidermal growth factor receptor 3 (HER3)
BxPC-3
emtansine
DM1
albumin binding domain
affibody drug conjugate (AffiDC)
ISBN 3-0365-5222-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Novel Anti-cancer Agents and Cellular Targets and Their Mechanism
Record Nr. UNINA-9910619465503321
Allison Simon J  
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Developments in Cancer Systems Biology
Recent Developments in Cancer Systems Biology
Autore Sinha Raghu
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (272 p.)
Soggetto topico Medicine
Soggetto non controllato Sestrin2
lung cancer
knockdown
cancer progression
bioinformatics
patient survival
lung adenocarcinoma
circulating miR-1246
glycosaminoglycan binding
prognosis
PI3K-Akt signaling pathways
TargetScan
UBE2C
cancer systems biology
experimental model systems
next-generation sequencing
single-cell sequencing
patient-derived xenografts
patient-derived organoids
triple-negative breast cancer
personalized medicine
computational methods
drug repurposing
clinical trials
cancer stem cells
ETS
Elk-1
stem cell
microarray
brain-tumor-initiating cell (BTIC)
pancreatic cancer
systems biology
omics
biomarker
genomics
transcriptomics
proteomics
metabolomics
glycomics
metagenomics
Ets
PEA3
Ets-1
glioma
optical genome mapping
solid tumors
cancer genomics
breast
ovarian
cancer
TCGA
non-small-cell lung cancer
lung adenocarcinoma (LUAD)
lung squamous cell carcinoma (LUSC)
differential expression
SNV
CNV
risk group
signature
survival
renal cancers
protein interactome
diagnostic biomarker
prognostic biomarker
virtual screening
docking
acute myeloid leukemia
Boolean model
drug resistance
network
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557768503321
Sinha Raghu  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Special Issue Dedicated to Late Professor Takuo Okuda. Tannins and Related Polyphenols Revisited: Chemistry, Biochemistry and Biological Activities
Special Issue Dedicated to Late Professor Takuo Okuda. Tannins and Related Polyphenols Revisited: Chemistry, Biochemistry and Biological Activities
Autore Yoshida Takashi
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (316 p.)
Soggetto non controllato Coreopsis lanceolata L.
UV-Vis
methanogenesis
Lythraceae
flavanone
grape marc
TDDFT
Ephedra sinica
macrocyclic oligomer
triple-negative breast cancer
antioxidant
purple prairie clover
chalcone
neuraminidase
fatty acid synthase
(?)-epigallocatechin gallate
epidermal growth factor
NMR spectroscopy
Aluminum ion
Onagraceae
Hydrangea macrophylla
synthetic analogues
blue color development
amyloid-? peptide
FTIR
oseltamivir carboxylate
quantitative NMR
phloroglucinolysis
thin layer chromatography
European historic leathers
FASN inhibition
ECD
colorimetric tests
taxanes
cynandione A
conservation method
5-O-caffeoylquinic acid
ellagitannin
PC12
condensed tannin
Trapa taiwanensis Nakai
1H-NMR
Acacia
(?)-epigallocatechin 3-gallate
Geranium thunbergii
condensed tannins
immunomodulatory effect
Acacia mearnsii bark
Escherichia coli
oligomer
Horner–Wadsworth–Emmons reaction
lung tumor
Aspergillus fumigates
in vitro batch fermentation
metal complex
Myrtaceae
Cynanchum auriculatum
molecular interactions
phenolic glycoside
bamboo leaf extract
stability
Microsporum canis
Cynanchum wilfordii
thiolysis
anti-inflammation
hydrolysable tannin
geraniin
NGF
polyphenol
revision
ESI-mass
bioactivity
antifungal activities
interferon-?
antitumor effect
tannin composition
oenothein B
zanamivir
2-O-?-laminaribiosyl-4-hydroxyacetophenone
anticancer activity
proanthocyanidin
vegetable tanning
Dittrichia viscosa
differentiation
aurone
antioxidants
protein precipitation
apoptosis
polyphenolic FASN inhibitors
forage legume
biological activities
ultrahigh-resolution negative mode MALDI-TOF mass spectrometry
overlay method
spectroscopy
wattle tannin
immune checkpoint
hormesis
3-O-glucosyldelphinidin
gallotannin
proanthocyanidins
fatty acids
flavonol
inhibition
structure
Candida spp
Malassezia spp
ORAC assay
neuroprotection
crystal structure
tannins
ISBN 3-03897-835-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Special Issue Dedicated to Late Professor Takuo Okuda. Tannins and Related Polyphenols Revisited
Record Nr. UNINA-9910346671803321
Yoshida Takashi  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui